14 unknown. 14 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Unknown 14 |
| Phase 2 | 3 | Unknown 3 |
Follow Hematologic Neoplasms: new trials by email Literature Review of Hematologic Neoplasms trials Research Report on Hematologic Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors Shengxuening Tablet, Ferrous succinate - Hematological Malignancy, Cancer-Related Anemia | Phase 3 | Unknown | Zhongnan Hospital | 168 | 2023-02-07 | 2023-08-25 |
| Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Aminoglycosides intervention, Lack of protective isolation intervention, No systematic aminoglycosides intervention - standard arm - Sepsis, Septic Shock | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 340 | 2022-09-01 | 2022-07-05 |
| Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis Post-transplantation Cyclophosphamide at dose 25 mg/kg/day, Post-transplantation Cyclophosphamide at dose 50 mg/kg/day - Graft Versus Host Disease, Hematologic Malignancy | Phase 3 | Unknown | National Research Center for Hematology, Russia | 100 | 2022-01-01 | 2022-01-11 |
| Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS Azacitidine, all trans retinoic acid - AML, MDS | Phase 2 / Phase 3 | Unknown | The First Affiliated Hospital of Soochow University | 180 | 2021-05-01 | 2022-01-03 |
| Impact of the Immune System on Response to Anti-Coronavirus Disease 19 (COVID-19) Vaccine in Allogeneic Stem Cell Recipients (Covid Vaccin Allo) anti-COVID19 mRNA-based vaccine (BNT162b2, Comirnaty®, commercialized by Pfizer) - Coronavirus Disease 2019 (Covid19), Hematopoietic Neoplasms | Phase 3 | Unknown | University of Liege | 50 | 2021-03-22 | 2022-05-18 |
| Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours CAR-T cell therapy - Hematological Malignancy | Phase 2 / Phase 3 | Unknown | Shanxi Bethune Hospital | 30 | 2020-06-15 | 2024-02-02 |
| Early Palliative Care for Patients With Haematological Malignancies Early palliative care integration - Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 3 | Unknown | University Hospital, Clermont-Ferrand | 140 | 2019-03-14 | 2021-03-24 |
| Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT Imipenem - Antibacterial Prophylaxis, Hematological Malignancies | Phase 2 / Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 250 | 2018-12-01 | 2018-11-07 |
| Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells T-reg depleted DLI, Standard DLI - Hematological Malignancies, Regulatory T Cell Depletion | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 52 | 2018-02-22 | 2023-12-18 |
| Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients Methylprednisolone, Placebo - Pneumocystis, Steroids | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 222 | 2017-02-15 | 2020-10-06 |
| Laser Therapy Prevents Mucositis Oral in Chemotherapy for Bone Marrow Transplantation? Low level laser therapy - Oral Mucositis, Effects of Chemotherapy | Phase 3 | Unknown | Instituto Materno Infantil Prof. Fernando Figueira | 36 | 2015-01-01 | 2013-12-25 |
| Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation Anti-Thymocyte Globulin (Rabbit), Patients will receive a standard preparative regimen (i.e. one that does not contain Thymoglobulin) - Hematologic Malignancies | Phase 3 | Unknown | McMaster University | 198 | 2010-04-01 | 2010-10-08 |
| Exercise During Chemotherapy for Patients With Hematological Malignancies Aerobic exercise, Fatigue counseling - Hematological Diseases, Hematological Malignancies | Phase 3 | Unknown | Charite University, Berlin, Germany | 60 | 2009-05-01 | 2009-12-23 |
| Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain ketamine hydrochloride, pharmacogenomic studies, questionnaire administration - Cancer | Phase 3 | Unknown | University of Glasgow | 214 | 2009-04-01 | 2011-05-13 |
Leukemia, Myeloid, Acute (3) · Myelodysplastic Syndromes (3) · Neoplasms (3) · Hodgkin Disease (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Lymphoma (2) · Lymphoma, Large B-Cell, Diffuse (2) · Multiple Myeloma (2) · Myeloproliferative Disorders (2) · Anxiety Disorders (1) · Blast Crisis (1) · Bone Marrow Neoplasms (1) · Burkitt Lymphoma (1) · COVID-19 (1)
Hemic and Lymphatic Diseases (14) · Neoplasms by Site (14) · Hematologic Diseases (13) · Neoplasms (11) · Pathological Conditions, Signs and Symptoms (6) · Bone Marrow Diseases (5) · Immune System Diseases (5) · Neoplasms by Histologic Type (5) · Pathologic Processes (5) · Immunoproliferative Disorders (4) · Infections (4) · Leukemia (4) · Leukemia, Myeloid (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4)
Antilymphocyte Serum (1) · Azacitidine (1) · BNT162 Vaccine (1) · CVnCoV COVID-19 vaccine (1) · Cyclophosphamide (1) · Exercise (1) · Imipenem (1) · Immunotherapy, Adoptive (1) · Ketamine (1) · Low-Level Light Therapy (1) · Methylprednisolone (1) · Pharmacogenomic Testing (1) · Tretinoin (1) · ferrous succinate (1) · shengxuening (1)
Assistance Publique - Hôpitaux de Paris (3) · Charite University, Berlin, Germany (1) · Instituto Materno Infantil Prof. Fernando Figueira (1) · McMaster University (1) · Nanfang Hospital, Southern Medical University (1) · National Research Center for Hematology, Russia (1) · Shanxi Bethune Hospital (1) · The First Affiliated Hospital of Soochow University (1) · University Hospital, Clermont-Ferrand (1) · University of Glasgow (1) · University of Liege (1) · Zhongnan Hospital (1)
China (4) · France (3) · Belgium (1) · Brazil (1) · Canada (1) · Germany (1) · United Kingdom (1)
Barry J.A. Laird, MD (1) · Elena Parovichnikova, MD, D.Sc (1) · Elie Azoulay, MD PHD (1) · Fernando Dimeo, MD (1) · Flavia A de Orange, PhD (1) · Han Yue, Ph.D (1) · Irwin Walker, MD (1) · Liu Qifa (1) · Marie T. Fallon (1) · Virginie Lemiale, MD (1) · Xiaomin Zhang (1)
PMID 31756535, PMID 31958417, PMID 37341189, PMID 40652952, PMID 42558999
2016 (1)